You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 14, October 12, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Law and Medicine
 •Immunization
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Legal Concerns and the Influenza Vaccine Shortage

Michelle M. Mello, JD, PhD, MPhil; Troyen A. Brennan, MD, JD, MPH

JAMA. 2005;294:1817-1820.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Concerns have arisen that the paucity of suppliers of influenza vaccine for the US market, which contributed to the shortage of vaccine in 2004, is largely attributable to the legal liability that vaccine manufacturers face. For instance, in October 2004, President Bush signed into law the American Jobs Creation Act of 2004,1 adding influenza vaccine to the federal Vaccine Injury Compensation Program (VICP), the administrative scheme that is the first-line legal remedy for certain vaccine-related injuries. Although the introduction of the bill predated the 2004 flu vaccine shortage,2-3 it presaged public concern about how the legal environment may be affecting vaccine supplies. In October, a nongovernmental organization called the Club for Growth ran a full-page newspaper advertisement4 that read, "Can’t get a flu shot? Thank the trial lawyers." In the presidential debates, President Bush commented that manufacturers have . . . [Full Text of this Article]

The Legacy of Litigation and the No-Fault Alternative

Author Affiliations: Department of Health Policy and Management, Harvard School of Public Health (Drs Mello and Brennan) and Department of Medicine, Harvard Medical School (Dr Brennan), Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Preparing for Pandemic Influenza: California Confronts the Legal Implications
Macario et al.
Health Promot Pract 2009;10:573-578.
ABSTRACT  

Half-Dose Influenza Vaccine: Stretching the Supply or Wasting It?
Falsey
Arch Intern Med 2008;168:2402-2403.
FULL TEXT  

Administrative Compensation of Medical Injuries: A Hardy Perennial Blooms Again
Barringer et al.
Journal of Health Politics, Policy and Law 2008;33:725-760.
ABSTRACT  

The Patient's Right to Safety -- Improving the Quality of Care through Litigation against Hospitals.
Annas
NEJM 2006;354:2063-2066.
FULL TEXT  

Medical Countermeasures for Pandemic Influenza: Ethics and the Law
Gostin
JAMA 2006;295:554-556.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.